Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · Real-Time Price · USD

1.110

-0.040 (-3.48%)

At close: Aug 25, 2026, 4:00 PM EDT

1.130

+0.020 (1.80%)

After-hours: Aug 25, 2026, 7:30 PM EDT

Tiziana Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.01	3.72	1.18	18.12	42.19
Cash & Short-Term Investments	4.01	3.72	1.18	18.12	42.19
Cash Growth	7.68%	214.79%	-93.47%	-57.04%	-35.91%
Other Receivables	4.08	3.64	5.93	5.86	5.27
Receivables	4.08	3.64	5.93	5.86	5.27
Prepaid Expenses	0.29	0.09	0.1	0.17	1.19
Other Current Assets	0.17	0.05	0.12	0.13	0.04
Total Current Assets	8.55	7.51	7.34	24.28	48.68
Property, Plant & Equipment	0.5	0.19	0.29	0.39	0.02
Long-Term Investments	2.44	3.59	4.55	1.81	-
Other Intangible Assets	-	-	-	-	0.13
Total Assets	11.5	11.28	12.18	26.48	48.83

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.17	5.58	4.14	4.96	4.41
Accrued Expenses	3.29	1.65	2.25	1.57	1.78
Current Portion of Leases	0.22	0.11	0.14	0.12	-
Current Unearned Revenue	0.53	-	-	-	-
Other Current Liabilities	-0	0.01	0.01	0.01	1.37
Total Current Liabilities	11.21	7.35	6.54	6.66	7.55
Long-Term Leases	0.23	-	0.11	0.24	-
Total Liabilities	11.44	7.35	6.65	6.91	7.55

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.12	0.11	0.1	0.1	0.1
Additional Paid-In Capital	34.66	23.11	16.49	15.6	15.6
Retained Earnings	-163.11	-144.83	-133.68	-116.26	-108.06
Treasury Stock	-	-	-1.57	-1.32	-
Comprehensive Income & Other	128.38	125.55	124.19	121.46	133.65
Shareholders' Equity	0.05	3.94	5.54	19.57	41.28
Total Liabilities & Equity	11.5	11.28	12.18	26.48	48.83

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.46	0.11	0.25	0.37	-
Net Cash (Debt)	3.55	3.62	0.94	17.76	42.19
Net Cash Growth	-1.77%	286.54%	-94.73%	-57.91%	-35.37%
Net Cash Per Share	0.03	0.03	0.01	0.17	0.43
Filing Date Shares Outstanding	120.51	111.46	101.51	100.59	102.27
Total Common Shares Outstanding	120.51	111.46	101.51	100.59	102.27
Working Capital	-2.66	0.16	0.8	17.62	41.13
Book Value Per Share	0.00	0.04	0.05	0.19	0.40
Tangible Book Value	0.05	3.94	5.54	19.57	41.15
Tangible Book Value Per Share	0.00	0.04	0.05	0.19	0.40

SEC Filings: 10-K · 10-Q